Page 1 of 3
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`SERIAL NO:
`
`77/010647
`
`MARK: ZUCOL
`
`CORRESPONDENT ADDRESS:
`
`Gordon M. Walker
`
`Nature's Way Products, Inc.
`137_5 M9“main SP“'ngS PKWY
`SP““g"‘"° UT 846636009
`
`GENERAL TRADEMARK INFORMATION:
`http://www.uspto.gov/main/trademarks.htm
`
`APPLICANT:
`
`Nature's Way Products, Inc.
`
`CORRESPONDENT’ S REFERENCE/DOCKET
`NO:
`
`N/A
`CORRESPONDENT E-MAIL ADDRESS:
`
`REQUEST FOR RECONSIDERATION DENIED
`
`ISSUE/MAILING DATE:
`
`Applicant is requesting reconsideration of a final refusal issued/mailed 11/5/07.
`
`Afier carefiil consideration ofthe law and facts of the case, the examining attorney must deny the
`request for reconsideration and adhere to the final action as written since no new facts or reasons have
`been presented that are significant and compelling with regard to the point at issue.
`
`Accordingly, applicant’s request for reconsideration is denied. The time for appeal runs from the date
`the final action was issued/mailed. 37 C.F.R. Section 2.64(b); TMEP Section 715.03(c). If applicant
`has already filed a timely notice of appeal, the application will be forwarded to the Trademark Trial and
`Appeal Board (TTAB).
`
`In further support of the final refusal, the following is added to the record:
`
`SECTION 2(d) REFUSAL — LIKELIHOOD OF CONFUSION MAINTAINED
`
`Registration of the applied-for mark is refiased because of a likelihood of confusion with the mark in
`U.S. Registration No. 3194667. Trademark Act Section 2(d), 15 U.S.C. §lO52(d); see TMEP §§1207.01
`et seq.
`
`Comparison of the Marks
`
`In a likelihood of confusion determination, the marks are compared for similarities in their appearance,
`
`file://\\ticrs—ais-01\ticrsexport\HtmlToTifiInput\REC00012008_06_11_11_4l_30_'ITABO...
`
`6/ l. 1/2008
`
`

`
`Page 2 of 3
`
`sound, meaning or connotation and commercial impression. In re E. I. du Pont de Nemours & C0., 476
`F.2d 1357, 1361, 177 USPQ 563, 567 (C.C.P.A. 1973); TMEP §1207.01(b). Similarity in any one of
`these elements may be sufficient to find a likelihood of confusion. In re White Swan Ltd., 8 USPQ2d
`1534, 1535 (TTAB 1988); In re Lamson Oil Co., 6 USPQ2d 1041, 1043 (TTAB 1987); see TMEP
`§l207.01(b).
`
`Applicant has stated that the analysis that was performed in the final action was without legal authority.
`
`It is true that the marks are compared in their entireties under a Trademark Act Section 2(d) analysis.
`See TMEP §1207.0l(b). Nevertheless, one feature of a mark may be recognized as more significant in
`creating a commercial impression. Greater weight is given to that dominant feature in determining
`whether there is a likelihood of confusion. In re Nat '1 Data Corp., 753 F.2d 1056, 224 USPQ 749 (Fed.
`Cir. 1985); Tektronix, Inc. v. Daktronics, Inc., 534 F.2d 915, 189 USPQ 693 (C.C.P.A. 1976); In reJM.
`Originals Inc., 6 USPQ2d 1393 (TTAB 1987); see TMEP §1207.0l(b)(viii), (c)(ii). The last Office
`action specifically stated the reasons for holding the word ZACOL as the dominant wording in the
`registered mark. The wording is dominant visually and in terms of significance. The attached
`registrations showed frequent use of letters at the end of marks in the pharmaceutical industry. As a
`result ofthis frequent use, these registrations tend to show that consumers are accustomed to seeing such
`additional letters and thus, would not likely look as closely to added letters when differentiating the
`source of marks and their respective products.
`
`Comparison of the Goods
`
`The goods and/or services of the parties need not be identical or directly competitive to find a likelihood
`of confusion. See Safety-Kleen Corp. v. Dresser Indus, Inc., 518 F.2d 1399, 1404, 186 USPQ 476, 480
`(C.C.P.A. 1975); TMEP §1207.0l(a)(i). Rather, they need only be related in some manner, or the
`conditions surrounding their marketing are such that they would be encountered by the same purchasers
`under circumstances that would give rise to the mistaken belief that the goods and/or services come from
`a common source. In re Total Quality Group, Inc., 51 USPQ2d 1474, 1476 (TTAB 1999); TMEP
`§1207.01(a)(i); see, e.g., On-line Careline Inc. v. Am. Online Inc., 229 F.3d 1080, 1086-87, 56 USPQ2d
`1471, 1475-76 (Fed. Cir. 2000); In re Martin ‘s Famous Pastry Shoppe, Inc., 748 F.2d 1565, 1566-68,
`223 USPQ 1289, 1290 (Fed. Cir. 1984).
`Applicant has also made repeated references to app1icant’s website as well applicant’s own searches of
`the marketplace; however, please note that an applicant may not restrict the scope of the goods covered
`in a registration by extrinsic argument or evidence. See, e.g., In re Bercut-Vandervoort & Co., 229
`USPQ 763, 764 (TTAB 1986).
`It is also repeated that a determination of whether there is a likelihood of confusion is made solely on the
`basis of the goods and/or services identified in the application and registration, without limitations or
`restrictions that are not reflected therein. In re Dakin ’s Miniatures, Inc., 59 USPQ2d 1593, 1595 ('I'I‘AB
`1999); TMEP §1207.01(a)(iii). Ifthe cited registration describes the goods and/or services broadly and
`there are no limitations as to their nature, type, channels of trade or classes of purchasers, then it is
`presumed that the registration encompasses all goods and/or services of the type described, that they
`move in all normal charmels of trade, and that they are available to all potential customers. In re
`Linkvest SA., 24 USPQ2d 1716, 1716 (TTAB 1992), In re Elbaum, 211 USPQ 639, 640 (TTAB 1981);
`TMEP §1207.01(a)(iii).
`
`It is therefore maintained that it is proper for the examining attorney to assume that applicant’s “anti-
`infectives” may be for use in the respiratory tract.
`In that case, the goods of the parties would be very
`highly related.
`
`Regardless, the examining attorney attaches additional evidence showing that one entity in the
`
`file://\\ticrs-ais-O1\ticrsexport\HtmlToTiflInput\REC000 12008_06_1 1_1 1_41_30_TTABO...
`
`6/1 1/2008
`
`

`
`Page 3 of 3
`
`pharmaceutical industry often markets preparations for the respiratory tract as well as for the digestive
`tract under the same mark. Please note that such printouts have been held to have probative value to the
`extent that they serve to suggest that the goods and/or services listed therein are of a kind that may
`emanate from a single source. In re Infinily Broad. Corp., 60 USPQ2d 1214, 1217-18 (TTAB 2001); In
`re Albert Trostel & Sons C0,, 29 USPQ2d 1783, 1785-86 (TTAB 1993); In re Mucky Duck A/Iustard Co.,
`6 USPQ2d 1467, 1470 n.6 (TTAB 1988); TMEP §1207.01(d)(iii).
`
`Regarding applicant’s arguments concerning the fact that registrant appears to only sell its products in
`Italy, please note that as a Section 66(a) applicant, it was not required to show use in commerce prior to
`registration. Section 68(a)(3) ofthe Trademark Act, 15 U.S.C. §1l41h(a)(3). However, after
`registration, periodic affidavits of use or excusable nonuse are required to maintain a registered
`extension of protection. Section 71 of the Trademark Act, 15 U.S.C. §1141k. Nevertheless, it is proper
`for the examining attorney to cite a 66(a) registration under Section 2(d). The Trademark Act requires
`that any registered mark be cited against a pending application if the examining attorney determines that
`confusion is likely. The extract from 15 U.S.C. §1052 states the following: “No trademark by which
`the goods of the applicant may be distinguished from the goods of others shall be refused registration on
`the principal register on account of its nature unless it
`(d) Consists of or comprises a mark which so
`resembles a mark registered in the Patent and Trademark Office.” The Trademark Manual of Examining
`Procedure also does not single out 66(a) registrations. It states: “In the ex parte examination of a
`trademark application, a refusal under §2(d) is normally based on the examining attorney’s conclusion
`that the applicant’s mark, as used on or in connection with the specified goods or services, so resembles
`a registered mark as to be likely to cause confiision.” TMEP §1207.01.
`
`Therefore, based on the totality of arguments and evidence presented, the refusal of registration under
`Section 2(d) is maintained and the request for reconsideration is DENIED.
`
`/Michelle E. Dubois/
`Michelle E. Dubois
`
`Trademark Attorney
`U.S. Patent & Trademark Office
`Law Ofiice 107
`
`(571) 272-5887
`
`STATUS CHECK: Check the status of the application at least once every six months from the initial
`filing date using the USPTO Trademark Applications and Registrations Retrieval (TARR) online system
`at http://tarr.uspto.gov. When conducting an online status check, print and maintain a copy ofthe
`complete TARR screen. Ifthe status of your application has not changed for more than six months,
`please contact the assigned examining attorney.
`
`file://\\ticrs-ais-01\ticrsexport\HtmlToTiffInput\RE C0O012008_06_1 1_1 1_41_30__'ITABO...
`
`6/ 1 1/2008
`
`

`
`Print: Jun 3, 2008
`
`75650659
`
`DESIGN MARK
`
`Serial Number
`1 5 6 50 65 9
`
`Status
`REGISTERED
`
`Word Mark
`MAXAID
`
`Standard character Mark
`No
`
`Registration Number
`2 4 9 4 7 6 5
`
`Date Registered
`2001/10/02
`
`Type of Marl:
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing code
`[11 TYPED DRAWING
`
`Owner
`Thompson, Fred R., III INDIVIDUAL UNITED STATES 10414 Butia Place
`Tampa FLORIDA 33618
`
`Goodstservices
`Class Status -— ACTIVE.
`
`IC 005.
`
`US
`
`006 018 O44 O46 051 052.
`
`G & S:
`
`Dietary supplements in the nature of nutraceuticals; dietary
`supplements for medical use: and over the counter pharmaceuticals
`consisting of allergy preparations, analgesics, acid reducer,
`anthelmintic, anti—diarrhea, antiemitic, antacid, appetite
`suppressant, cough and cold preparations, gastrol intestinal,
`hemorrhoidal,
`laxative, sleep alds, stimulants, stool softener, and
`weight control preparations. First Use: 2001/03/01- First Use In
`Commerce: 2001f03/01.
`
`Filing Date
`1999/03/05
`
`Examining Attorney
`MICHOS,
`JOHN E.
`
`

`
`MAXAID
`
`

`
`Print: Jun 3, 2008
`
`76018543
`
`DESIGN MARK
`
`Serial Number
`76018543
`
`Status
`REGISTERED
`
`Word Mark
`PI-IARMA TRUST
`
`standard character Mark
`No
`
`Registration Number
`2652388
`
`Date Registered
`2002/11/19
`
`Type of Mark
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing code
`[1] TYPED DRAWING
`
`Owner ~
`LEINER HEALTH SERVICES CORP. CORPORATION DELKWHRE 901 East 233rd
`Street Carson CALIFORNIA 90745
`
`Goodstservices
`Class Status -— ACTIVE.
`
`IC 005.
`
`US
`
`006 018 044 046 051 052.
`
`G & S:
`
`vitamins and dietary food supplements; pharmaceutical preparations,
`namely,
`laxatives, antacids, analgesics and preparations for the
`treatment of colds and cold symptoms, allergy remedies, cough
`remedies, decongestants and antihistamines, nasal preparations, sinus
`analgesics dimenhydrinate tablets useful in the prevention and
`treatment of motion sickness, nausea and vomiting: pharmaceutical
`preparations for use as a stimulant and for the treatment of sleep
`disorders; digestive aids, antidiarrheals, eye drops, first aid
`antiseptics, hemorrhoidal preparations, medicated lip balm, medicated
`sun screen and throat lozenges and sprays. First Use: 2002/06/17.
`First Use In Commerce: 2002/06/1?.
`
`Prior Registrationts)
`1884193;1884194
`
`Filing Date
`
`

`
`Print: Jun 3, 2008
`
`760185-I-3
`
`2000/04/04
`
`Examining Attorney
`CHICOSKI,
`JENNIFER
`
`Attorney of Record
`MICHAEL A. PAINTER
`
`

`
`PHARMA TRUST
`
`

`
`Print: Jun 3, 2008
`
`76023670
`
`DESIGN MARK
`
`Serial Number
`76023670
`
`Status
`REGISTERED
`
`Word Mark
`LINK PHARMACEUTICALS
`
`Standard character Mark
`No
`
`Registration Number
`2583316
`
`Date Registered
`2002/06/18
`
`Type of Mark
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing code
`[1] TYPED DRAWING
`
`Chuner
`
`Anabolic Laboratories, Inc. CORPORATION CALIFORNIA 17802 Gilette
`Avenue Irvine CALIFORNIA 92614
`
`Goodsfservices
`Class Status —— ACTIVE.
`
`IC 005.
`
`US
`
`006 018 044 046 051 052.
`
`G & S:
`
`Generic and brand end pharmaceutical preparations for the treatment of
`respiratory conditions, gastrointestinal diseases, cardiovascular .
`diseases, endochronologic disorders, metabolic disorders, nutritional
`deficiencies and analgesics. First Use: 2001/06/25. First Use In
`Commerce: 2001/06/25.
`
`Disclaimer statement
`NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO USE "PHARMACEUTICALS" APART
`FROM THE MARK AS SHOWN.
`
`Filing Date
`2000/04!l1
`
`Examlnlng Attomay
`FLETCHER, TRACY
`
`

`
`Print: Jun 3. 2003
`
`76023670
`
`Attorney of Record
`Catherine L . Donohue
`
`

`
`LINK PHARMACEU'l'lCALS
`
`

`
`Print: Jun 3, 2008
`
`76261053
`
`TYPED DRAWING
`
`Serial Number
`76261053
`
`Status
`REGISTERED
`
`Word Mark
`SYNTRION
`
`standard Character Mark
`No
`
`Registration Number
`2929181
`
`Date Registered
`2005/O3/01
`
`Type of Mark
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing code
`[1] TYPED DRAWING
`
`Owner
`Syntrion Gmbl-I CORPORATION FED REP GERMANY Auf dem Buehl 2 Calw FED REP
`GERMANY D-75365
`
`Goodsrservices
`Class Status -- ACTIVE.
`
`IC 005.
`
`US
`
`006 O18 O44 046 051 052.
`
`G & S:
`
`Dietary supplements and Homeopathic and Herbal preparations for use in
`the treatment of viral, fungal and bacterial infections, flu and
`common cold symptoms, namely congestion, coughs, sore throat, fever,
`swollen glands, and disorders of the circulatory, gastrointestinal,
`respiratory and urinary tract systems. First Use: 2001/O1/O1. First
`Use In Commerce: 2001/07/01.
`
`Filing Date
`200l!'05/24
`
`Examining Attorney
`CARROLL, DORITT "L.
`
`Attorney Of RECON!
`Emalee G. Murphy
`
`

`
`Print: Jun 3, 2008
`
`76338029
`
`DESIGN MARK‘
`
`Serial Number
`76338029
`
`Status
`REGISTERED
`
`Word Mark
`W WARRICK PHARMACEUTICALS
`
`Standard character Mark
`No
`
`Registration Number
`2735994
`
`Date Registered
`2003/O?/15
`
`Type of Mark
`TRADEMARK
`
`Register
`PR INCI PAL
`
`‘
`Mark Drawing code
`[3] DESIGN PLUS WORDS, LETTERS AND/OR NUMBERS
`
`(ANNE?
`
`WARRICK PHARMACEUTICALS CORPORATION CORPORATION DELAWARE 12125 MOIA
`BLVD RENO NEVADA 895062600
`
`Goodstservices
`G & S:
`006 018 044 046 051 052.
`US
`IC 005.
`Class Status —— ACTIVE.
`pharmaceutical preparations used in the treatment of cardiovascular,
`respiratory, dermatological, gastrointestinal, central nervous system
`and musculoskeletal system disorders. First Use: 1996/00/00. First
`Use In Commerce: 1996/00/00.
`
`Dlsclalmer statement
`NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO USE "PHARMACEUTICALS" APART
`FROM THE MARK AS SHOWN.
`
`Flllng Date
`2001/11/14
`
`Examining Attorney
`RIRIE, VERNA BETH
`
`Attorney of Record
`
`

`
`Print: Jun 3, 2008
`
`JOEL WIENER
`
`76338029
`
`

`
`
`
`Warrick "
`PHARMACEUTICALS
`
`

`
`Print: Jun 3. 2008
`
`78180621
`
`TYPED DRAWING
`
`Serial Number
`78180621
`
`status
`REGISTERED
`
`Word Mark
`TAKE 2
`
`Standard character Mark
`No
`
`Registration Number
`2877051
`
`Date Registered
`2004,/08/24
`
`Type of Mark
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing code
`:11 TYPED DRAWING
`
`OWTIBP
`
`Lil‘ Drug Store Products, Inc. CORPORATION IOWA P.O. Box 1883 Cedar
`Rapids IOWA 52406
`
`Goodsfservices '
`Class status —— ACTIVE.
`
`IC 005.
`
`us
`
`006 018 044 046 051 052.
`
`G & s:
`
`UNIT DOSE NON—PRESCRIPTION DRUG ITEMS SOLD OVER THE COUNTER, NAMELY,
`ANALGESICS, ANTACIDS, PREPARATIONS FOR TREATING COUGHS, COLDS AND FLU,
`ALLERGY RELIEF MEDICATIONS, PREPARATIONS USED IN THE TREATMENT OF
`GASTROINTESTINAL DISORDERS, PREPARATIONS USED IN THE TREATMENT OF
`SINUS CONGESTION SYMPTOMS, SLEEPING AIDS, MOTION SICKNESS TREATMENT
`PREPARATIONS, CAFFEINE PREPARATIONS FOR STIMULATIVE USE. First Use:
`
`1994/ll/O8. First Use In Commerce: 1994/11/08,
`
`Prior Registratioms)
`1993921
`
`Filing Date
`2002/10/31
`
`Examining Attorney
`RIRIE, VERNA BETH
`
`

`
`Print: Jun 3, 2008
`
`78180621
`
`Attumey of Record
`James C . Nemmere
`
`

`
`Print: Jun 3, 2008
`
`78598232
`
`DESIGN MARK
`
`Serial Number
`78598232
`
`status
`REGISTERED
`
`Word Mark
`BYSTOLIC
`
`Standard Character Mark
`Yes
`
`Registration Number
`3412780
`
`Date Registered
`2008/O4/15
`
`Type of Mark
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing code
`[4] STANDARD CHARATER MARK
`
`Owner
`
`Forest Laboratories, Inc. CORPORATION DELAWARE 909 Third Avenue New
`York NEW YORK 10022
`
`_
`Goodsfservices
`G & S:
`006 018 O44 046 051 052.
`US
`IC 005.
`Class Status —— ACTIVE.
`Pharmaceutical preparations for the treatment of pain, hypertension,
`cardiovascular, respiratory, central nervous system and
`gastrointestinal diseases and disorders. First Use: 2008/01,207.
`First Use In Commerce: 2008/01/O7.‘
`
`Filing Date
`2005/03/30
`
`Examining Attorney
`SPARACINO, MARI‘-C
`
`Attorney of Record
`Christopher Serbagi
`
`

`
`
`
`

`
`Print: Jun 3, 2008
`
`78649829
`
`DESIGN MARK
`
`Serial Number
`78649829
`
`status
`REGISTERED
`
`Word Mark
`ASALIXX
`
`standard character Mark
`Yes
`
`Registration Number
`3119926
`
`Date Registered
`2006/O?/25
`
`Type of Mark
`TRADEMARK
`
`Register
`PRINCIRAL
`
`Mark Drawing code
`:4) STANDARD CHARACTER MARK
`
`Owner
`
`Bionorica AG AKTIENGESELLSCHAFT {AG} FED REP GERMANY D-92318
`Kerschensteinerstrasse l1—15 Neumarkt FED REP GERMANY
`
`Goodstservices
`
`US O06 O18 044 046 051 052.
`IC 005.
`Class Status —— ACTIVE.
`dietary supplements: dietary food supplements; pharmaceutical
`preparations made from willow bark, namely for use in the treatment of
`migraine, arthritis, osteoarthritis, fever, cough, cold, diarrhea,
`pain, menstrual syndromes and pain, and alzheimer's disease. First
`Use: 2005f03/07. First Use In Commerce: 2005/O3/07.
`
`G & S:
`
`Prior Registration(s)
`2555534
`
`Filing Date
`2005/05/13
`
`Examining Attorney
`WELLS , KELLEY
`
`Attorney of Record
`
`

`
`Print: Jun 3, 2008
`
`78649829
`
`John Alumit
`
`

`
`
`
`

`
`Print: Jun 3, 2008
`
`78664203
`
`DESIGN MARK
`
`Serial Number
`?8664203
`
`Status
`REGISTERED
`
`Word Mark
`OTCEUTICAL
`
`Standard Character Mark
`Yes
`
`Registration Number
`3175496
`
`Ekflelhgfisuued
`2006/ll/21
`
`Type of Mark
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing code
`[4] STANDARD CHARACTER MARK
`
`Owner
`INC. CORPORATION DELAWARE 135 BEAVER STREET WALTHAM
`AJG BRANDS,
`MASSACHUSETTS 02452
`
`Goodsfservices
`Class Status —— ACTIVE.
`
`IC 005.
`
`US O06 018 044 O46 O51 052.
`
`G & S:
`
`Vitamin and mineral supplements; Herbal, dietary and food supplements;
`Nutraceuticals foruse as a dietary supplement and for use for the
`prevention and treatment of diseases and disorders of the audiovisual
`
`systems, cardiovascular systems, central nervous systems, digestive
`systems, endoorinologio systems, gastroenterologic systems,
`genito-urinary systems, hematology, mental and psychologic
`functioning, musculo-skeletal systems, nephrologic systems,
`ophthalmologic systems, respiratory system, sensory systems, and skin
`and body tissues, and for the treatment of pain and cancer;
`Pharmaceutical preparations for the prevention and treatment of
`diseases and disorders of the audiovisual systems, cardiovascular
`systems, central nervous systems, digestive systems, endocrinologic
`systems, gastroenterologic systems, genito—urinary systems,
`hematology, mental and psychologic functioning, musoulo-skeletal
`systems, nephrologic systems, ophthalmologic systems, respiratory
`system, sensory systems, and skin and body tissues, and for the
`
`-1-
`
`

`
`Print: Jun 3, 2008
`
`78664203
`
`treatment of pain and cancer. First Use: 2005/02/00. First Use In
`Commerce: 2005/O2/O0.
`
`Filing Data
`2005/07/06
`
`Examining Attorney
`POWER , MARGARET
`
`Attorney or Record
`Richard L. Morris Jr, Esq
`
`

`
`OTCEUTICAL
`
`

`
`Print: Jun 3. 2008
`
`78710970
`
`DESIGN MARK
`
`Serial Number
`78710970
`
`status
`REGISTERED‘
`
`Word Mark
`ACTELION
`
`standard character Mark
`Yes
`
`RBQHNHRHINUWHNW
`3148269
`
`Date Registered
`2006/09/26
`
`Type of Mark
`TRADEMARK
`
`Register
`PRINCIPAL
`
`Mark Drawing code
`[4] STANDARD CHARACTER MARK
`
`Owner
`Actelion Pharmaceuticals, Ltd CORPORATION SWITZERLAND Gewerbestrasse
`16 Allschwil SWITZERLAND 4123
`
`Goodstservices
`Class Status -— ACTIVE.
`
`IC 005.
`
`US
`
`006 018 044 046 051 052.
`
`G & S:
`
`PHARMACEUTICAL PREPARATIONS FOR HUMAN AND VETERINARIAN USE, NAMELY,
`MEDICINES ACTING ON THE CARDIOVASCULAR SYSTEM, CHEMOTHERAPEUTICS,
`MEDICINES ACTING ON THE CENTRAL NERVOUS AND PERIPHERAL SYSTEM,
`MEDICINES ACTING ON THE RESPIRATORY SYSTEM, MEDICINES ACTING ON THE
`DIGESTIVE SYSTEM AND RELATED GLANDS, MEDICINES ACTING ON THE URINARY
`SYSTEM,
`IMMUNISUPPRESANTS, ANTI
`INFLAMMATORY, ANTI-ALLERGIC,
`HYPOSENSITIZING AND ANTI-TOXINS MEDICINES ACTING ON BLOOD AND
`HEMATOPOEITIC ORGANS. First Use: 2001/01/15. First Use In Commerce:
`2001/01/15 .
`
`Filing Date
`2005/09/12
`
`Examlnlng Attorney
`RINKER, ANTHONY
`
`

`
`Print: Jun 3, 2008
`
`78710970
`
`Attorney of Record
`Jane Wright-Mitchell
`
`

`
`
`
`

`
`Print: Jun 3. 2008
`
`78724371
`
`DESIGN MARK
`
`Serial Number
`7 8 7 2 4 3 7 1
`
`Status
`REGISTERED
`
`Registration Number
`3437854
`
`Date Registered
`2008/05/27
`
`Type of Mark
`TRADEMARK
`
`Register
`PRINCIRAL
`
`Mark Drawing Code
`:2; DESIGN ONLY
`
`Owner
`Holopack International Corp. CORPORATION SOUTH CAROLINA Carolina
`Research Park One Technology Circle Columbia SOUTH CAROLINA 29203
`
`Goodsiservices
`Class Status -- ACTIVE.
`
`IC 005.
`
`US
`
`006 018 044 046 051 052.
`
`G & S:
`
`Pre-filled, single dose containers containing pharmaceuticals for the
`treatment of colds, allergies, coughs, sinus ailments, pain,
`gastrointestinal ailments, and fever; pre—fil1ed, single dose
`containers containing nutritional supplements in the nature of
`Vitamins and herbal supplements and pre-filled, single dose containers
`containing washes, namely, ear and eye washes. First Use: 2007/08/01.
`First Use In Commerce: 2007/08/01.
`
`Colors claimed
`Color is not claimed as a feature of the mark.
`
`Filing Date
`2005/09/30
`
`Examining Attorney
`HARDY , TARA}-I
`
`Attorney of Record
`Marcia T. Greoi
`
`

`
`-‘:3’;Kai,i1.:
`
`!
`
`mm(xafi‘’MA§“V\
`
`4
`.
`/
`v‘a<-i»oe«an.z(‘.»xx<9yx
`»~» =s".,3“‘*‘,,n..
`. ,x..,.,w-
`Q.
`‘
`
`/
`
`,
`
`«V
`
`
`
`.
`.
`x
`>_
`_é
`5
`' x.
`‘
`,
`.
`°n‘%-2‘1FI- X/u3fx{fY
`,
`»
`'¢‘s"'x’“"‘ $wt‘§
`._
`~‘
`,
`..
`'
`w
`’°°‘ was
`‘
`'».*<
`xk«x,z\
`V
`V
`V
`1
`(
`I
`..
`.
`X .m
`:§~»’3‘?>«;=<xw«*r“’-I §«.’s“‘5?sx$}§ T
`’
`
`ism»: /.°-:~(;m‘ t‘¢".»vh.A ymigfijw u .» ..l.. x 5.‘. - A
`
`,:.fi.“/4;
`' “'2 «gr “\
`I
`V
`
`I
`"
`
`.
`
`V
`
`-
`
`:
`
`,
`
`‘
`
`-
`
`.'
`
`I
`
`»
`
`M
`
`Kfg,
`.
`
`‘I
`
`\
`
`
`
`

`
`Print: Jun 3, 2008
`
`78789030
`
`DESIGN MARK
`
`Serial Number
`7 8 7 8 9 0 3 0
`
`Status
`REGISTERED
`
`Word Mark
`ATENDA SPECIALTY INFUSION PHARMACY
`
`standard Character Mark
`Yes
`
`Regmmafionhhnnber
`342839?
`
`Date Registered
`2008/O5/13
`
`Type of Mark
`TRADEMARK; SERVICE MARK
`
`Register
`PRINCIPAL
`
`Mark Drawing code
`(4) STANDARD CHARACTER MARK
`
`thuner
`Atenda Healthcare Solutions, Inc. CORPORATION FLORIDA Suite 18 15712
`S.W. 41st Street Davie FLORIDA 33331
`
`Goodsfservices
`
`G & S: dispensing of
`100 101.
`US
`IC 044.
`Class Status —- ACTIVE.
`pharmeceuticals. First Use: 2006/O9/01. First Use In Commerce:
`2006/09f0l.
`
`Goodsfservices
`G & 8: Medical
`026 039 044.
`US
`IC 010.
`Class Status -— ACTIVE.
`supplies, namely droppers for administration of medications sold
`empty,
`thermometers for medical purposes, elastic bandages, air
`mattresses for medical purposes, apparatus for physical training for
`medical use, braces for limbs and joints for medical purposes, gloves
`for medical use,
`injection needles for medical use, and latex medical
`gloves. First Use: 2006/O9/O1. First Use In Commerce: 2006/O9/01.
`
`Gnodsfservices
`Class Status -- ACTIVE.
`
`IC 005.
`
`US
`
`006 018 044 046 051 052.
`
`G s.
`
`:3:
`
`Allergy medicine, antiseptics and general purpose germicides,
`antacids, antibiotics, antihistamine, cold capsules, cough
`
`-1-
`
`

`
`Print: Jun 3, 2008
`
`78789030
`
`suppressants and drops, cream pain reliever medication, day and night
`cold medicine, decongestant tablets, diarrhea medication, enema
`preparations, eye drops, flu medicine, suppositories, hydrocortisone
`cream,
`laxatives,
`lubricating jelly for medical purposes, medicated
`mouthwash, multi—antibiotio cream, nasal spray preparations, pain
`relievers, namely, aspirin and non-aspirin, saline solution for
`contact lenses, sinus tablets, sore throat lozenges, adhesive
`bandages, bandages for dressings, and bandages for skin wounds. First
`Use: 2006/09/01. First Use In Commerce: 2006/09/01.
`
`Prior Rogistratioms)
`32se339;3327o95
`
`Disclaimer Statement
`NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO USE "Specialty Infusion
`Pharmacy" APART FROM THE MARK AS SHOWN.
`
`Filing Date
`2006/01/11
`
`Examining Attorney
`FRIEDMAN, HOWARD
`
`Attorney of Record
`Gabrielle C. Bozza
`
`

`
`atenda Specialty Infusion
`Pharmacy